Higher degree of glycation of hemoglobin S compared to hemoglobin A measured by mass spectrometry: Potential impact on HbA1c testing

• Percent glycated βA, βS, and α hemoglobins were determined using LC-MS.
• LC-MS detected significantly higher glycation of βS chain (p < 0.001) versus βA.
• For HbS trait, calculations showed 5% higher total (α + β) glycation versus HbAA.
• The data support using boronate affinity to measure HbA1c in HbAS patients.

BackgroundGlycated hemoglobin (GHb), reported as HbA1c, is used as marker of long-term glycemia for diabetic patients. HbA1c results from boronate affinity methods are generally considered to be unaffected by most hemoglobin variants; this assumes comparable glycation of variant and non-variant (HbAA) hemoglobins. In this report, glycation of HbA beta chain (βA) and HbS beta chain (βS) for the most common Hb variant trait (HbAS) are examined.MethodsWe analyzed 41 blood samples from subjects with HbAS, both with and without diabetes. Using LC-MS, ratios of glycated HbS to glycated HbA were determined by comparison of areas under the curves from extracted ion chromatograms.ResultsGlycation of βS chains was significantly higher (p < 0.001) than βA chains; this difference was consistent across subjects. Total (α + β) glycated HbAS was theoretically estimated to be ~ 5% higher than glycated HbAA.ConclusionThis novel mass-spectrometric approach described allows for relative quantification of glycated forms of βS and βA. Although βS glycation was significantly higher than that of βA, the difference in total glycation of HbAS versus HbAA was smaller and unlikely to impact clinical interpretation of boronate affinity HbA1c results. These data support the continued use of boronate affinity to measure HbA1c in patients with HbAS.

Figure optionsDownload as PowerPoint slide